140 related articles for article (PubMed ID: 25930987)
41. Gynura procumbens causes vasodilation by inhibiting angiotensin II and enhancing bradykinin actions.
Poh TF; Ng HK; Hoe SZ; Lam SK
J Cardiovasc Pharmacol; 2013 May; 61(5):378-84. PubMed ID: 23328388
[TBL] [Abstract][Full Text] [Related]
42. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: role of bradykinin generation during ACE inhibition.
Mombouli JV; Vanhoutte PM
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S74-82. PubMed ID: 1282634
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIII.
Farias SL; Sabatini RA; Sampaio TC; Hirata IY; Cezari MH; Juliano MA; Sturrock ED; Carmona AK; Juliano L
Biol Chem; 2006 May; 387(5):611-6. PubMed ID: 16740133
[TBL] [Abstract][Full Text] [Related]
45. Molecular cloning and nucleotide sequence analysis of genes from a cDNA library of the scorpion Tityus discrepans.
D'Suze G; Schwartz EF; García-Gómez BI; Sevcik C; Possani LD
Biochimie; 2009 Aug; 91(8):1010-9. PubMed ID: 19470401
[TBL] [Abstract][Full Text] [Related]
46. Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro.
Neto-Neves EM; Montenegro MF; Dias-Junior CA; Spiller F; Kanashiro A; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):825-9. PubMed ID: 20406213
[TBL] [Abstract][Full Text] [Related]
47. Tryptic amaranth glutelin digests induce endothelial nitric oxide production through inhibition of ACE: antihypertensive role of amaranth peptides.
de la Rosa AP; Montoya AB; Martínez-Cuevas P; Hernández-Ledesma B; León-Galván MF; De León-Rodríguez A; González C
Nitric Oxide; 2010 Sep; 23(2):106-11. PubMed ID: 20435155
[TBL] [Abstract][Full Text] [Related]
48. Paramagnetic bradykinin analogues as substrates for angiotensin I-converting enzyme: Pharmacological and conformation studies.
Teixeira LG; Malavolta L; Bersanetti PA; Schreier S; Carmona AK; Nakaie CR
Bioorg Chem; 2016 Dec; 69():159-166. PubMed ID: 27837711
[TBL] [Abstract][Full Text] [Related]
49. The contribution of nitric oxide to cardiovascular status and responses to vasodilators in conscious, hypertensive, transgenic ((mRen-2)27) rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1998 May; 124(2):299-306. PubMed ID: 9641546
[TBL] [Abstract][Full Text] [Related]
50. Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs.
Fernandez JH; Neshich G; Camargo AC
Genet Mol Res; 2004 Dec; 3(4):554-63. PubMed ID: 15688321
[TBL] [Abstract][Full Text] [Related]
51. Scorpion venom peptides with no disulfide bridges: a review.
Almaaytah A; Albalas Q
Peptides; 2014 Jan; 51():35-45. PubMed ID: 24184590
[TBL] [Abstract][Full Text] [Related]
52. Cloning and characterization of a novel cDNA sequence encoding the precursor of a novel venom peptide (BmKbpp) related to a bradykinin-potentiating peptide from Chinese scorpion Buthus martensii Karsch.
Zeng XC; Li WX; Peng F; Zhu ZH
IUBMB Life; 2000 Mar; 49(3):207-10. PubMed ID: 10868911
[TBL] [Abstract][Full Text] [Related]
53. Effects of Tityus stigmurus (Thorell 1876) (Scorpiones: Buthidae) venom in isolated perfused rat kidneys.
Silva NA; Albuquerque CM; Marinho AD; Jorge RJ; Silva AG; Monteiro HS; Silva TD; Silva MV; Correia MT; Pereira TP; Martins AM; Menezes DB; Ximenes RM; Martins RD
An Acad Bras Cienc; 2016; 88 Suppl 1():665-75. PubMed ID: 27142547
[TBL] [Abstract][Full Text] [Related]
54. The inhibitory activity of HL-7 and HL-10 peptide from scorpion venom (Hemiscorpius lepturus) on angiotensin converting enzyme: Kinetic and docking study.
Setayesh-Mehr Z; Asoodeh A
Bioorg Chem; 2017 Dec; 75():30-37. PubMed ID: 28910674
[TBL] [Abstract][Full Text] [Related]
55. Tityus serrulatus venom peptidomics: assessing venom peptide diversity.
Rates B; Ferraz KK; Borges MH; Richardson M; De Lima ME; Pimenta AM
Toxicon; 2008 Oct; 52(5):611-8. PubMed ID: 18718845
[TBL] [Abstract][Full Text] [Related]
56. Vasorelaxant and hypotensive effects of a hydroalcoholic extract from the fruits of Nitraria sibirica Pall. (Nitrariaceae).
Senejoux F; Girard C; Aisa HA; Bakri M; Kerram P; Berthelot A; Bévalot F; Demougeot C
J Ethnopharmacol; 2012 Jun; 141(2):629-34. PubMed ID: 21864668
[TBL] [Abstract][Full Text] [Related]
57. Isolation, homology modeling and renal effects of a C-type natriuretic peptide from the venom of the Brazilian yellow scorpion (Tityus serrulatus).
Alves RS; Ximenes RM; Jorge AR; Nascimento NR; Martins RD; Rabello MM; Hernandes MZ; Toyama DO; Toyama MH; Martins AM; Havt A; Monteiro HS
Toxicon; 2013 Nov; 74():19-26. PubMed ID: 23911732
[TBL] [Abstract][Full Text] [Related]
58. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
Li GH; Qu MR; Wan JZ; You JM
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
[TBL] [Abstract][Full Text] [Related]
59. Ts14 from Tityus serrulatus boosts angiogenesis and attenuates inflammation and collagen deposition in sponge-induced granulation tissue in mice.
Cassini-Vieira P; Felipetto M; Prado LB; Verano-Braga T; Andrade SP; Santos RAS; Teixeira MM; de Lima ME; Pimenta AMC; Barcelos LS
Peptides; 2017 Dec; 98():63-69. PubMed ID: 27732900
[TBL] [Abstract][Full Text] [Related]
60. Enzymatic properties of venoms from Brazilian scorpions of Tityus genus and the neutralisation potential of therapeutical antivenoms.
Venancio EJ; Portaro FC; Kuniyoshi AK; Carvalho DC; Pidde-Queiroz G; Tambourgi DV
Toxicon; 2013 Jul; 69():180-90. PubMed ID: 23506858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
